Tag Archives: ASCO
Drug Innovation: Alive and Well at ASCO!
By John Otrompke.
This year’s annual meeting of the American Society of Clinical Oncology (ASCO), which ended on Tuesday, provided many examples of emerging therapies that offer new hope to even those patients with metastatic disease. Improved results in progression-free survival in clinical trials suggest that many forms of cancer may soon take on a more [...]
Posted in Events, Guest Blog, R&D Also tagged American Society of Clinical Oncology, drug development 1 Comment

Future Boom in Chronic Cancer Patients Likely to Change the Face of Disease, suggest ASCO Findings